<p>“*”Row percentage</p><p>“**”Reference value to calculate relative risk</p><p>Characteristics of presumptive MDR-TB patients with pre-diagnosis attrition in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 139].</p
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
*<p>Odds ratio given for a 10 year increase in age.</p><p>NA = Not applicable.</p><p>NS = Not signif...
<p>Demographic characteristics of patients with MDRTB registered for treatment between January 2015 ...
<p>“*”Row percentage</p><p>“**”Reference value to calculate relative risk</p><p>Characteristics of p...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
Association of clinical and socio-demographic factors with pre-treatment attrition among patients di...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
<p>Characteristics of MDR-TB suspects in a cohort of patients in Andhra Pradesh (N = 559).</p
<p>Risk factors for unfavorable treatment outcomes among patients with MDR-TB registered for treatme...
<p>*Patient states having been in contact with a person with active TB who is alive and whose episod...
National and regional characteristics and predictors of treatment initiation amongst 996 DR-TB patie...
Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...
Clinical and demographic profile of presumptive MDR-TB patients and confirmed MDR-TB patients under ...
Abstract Background Pre-diagnosis attrition needs to be addressed urgently if we are to make progres...
<p>Baseline demographic and clinical characteristics of MDR-TB patients (N = 1038).</p
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
*<p>Odds ratio given for a 10 year increase in age.</p><p>NA = Not applicable.</p><p>NS = Not signif...
<p>Demographic characteristics of patients with MDRTB registered for treatment between January 2015 ...
<p>“*”Row percentage</p><p>“**”Reference value to calculate relative risk</p><p>Characteristics of p...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
Association of clinical and socio-demographic factors with pre-treatment attrition among patients di...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
<p>Characteristics of MDR-TB suspects in a cohort of patients in Andhra Pradesh (N = 559).</p
<p>Risk factors for unfavorable treatment outcomes among patients with MDR-TB registered for treatme...
<p>*Patient states having been in contact with a person with active TB who is alive and whose episod...
National and regional characteristics and predictors of treatment initiation amongst 996 DR-TB patie...
Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...
Clinical and demographic profile of presumptive MDR-TB patients and confirmed MDR-TB patients under ...
Abstract Background Pre-diagnosis attrition needs to be addressed urgently if we are to make progres...
<p>Baseline demographic and clinical characteristics of MDR-TB patients (N = 1038).</p
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
*<p>Odds ratio given for a 10 year increase in age.</p><p>NA = Not applicable.</p><p>NS = Not signif...
<p>Demographic characteristics of patients with MDRTB registered for treatment between January 2015 ...